Literature DB >> 11684069

Remodeling of atrial dimensions and emptying function in canine models of atrial fibrillation.

Y Shi1, A Ducharme, D Li, R Gaspo, S Nattel, J C Tardif.   

Abstract

OBJECTIVES: Atrial tachycardia-induced remodeling (ATR) and ventricular tachypacing-induced heart failure (HF) create experimental substrates for atrial fibrillation (AF), and both have been reported to produce atrial dilation and hypocontractility. The relative importance of changes in atrial size and contractility in the two models is unknown. This study compared changes in atrial dimensions and emptying in ATR versus HF dog models and related them to AF promotion.
METHODS: In ATR dogs (n=11), the right atrium (RA) was paced at 400/min for 42 days. In HF dogs (n=10), the right ventricle was paced at 240 bpm for 2 weeks, followed by 3 weeks at 220 bpm. Transthoracic echocardiography was performed at baseline and weekly thereafter. At a terminal electrophysiological study, RA effective refractory period (ERP) was recorded and AF induced repeatedly by atrial burst pacing to measure mean AF duration (DAF).
RESULTS: Left atrial (LA) systolic area increased by 10.0% in ATR versus 48.2% in HF dogs (P=0.008), with significant time-dependent changes in HF (P=0.0001), but not ATR (P=0.16). LA diastolic area increased over time in both groups (P=0.004, 0.0001 for ATR and HF respectively), but increases were much larger in CHF (80.2%) compared to ATR (24.2%, P=0.0002). Similar findings were obtained for RA. Fractional area shortening (FAS) decreased by 19.4% (ATR) versus 41.8% (HF, P=0.007) in LA and 13.7% (ATR) versus 33.7% (HF, P=0.03) in RA. RA ERP correlated with DAF in ATR dogs (r=-0.79, P<0.001), but not in HF dogs (r=0.20, P=NS). DAF and diastolic areas of RA and LA were highly correlated (r=0.71, 0.77; P<0.01 for each) in HF dogs, but not in ATR dogs (r=-0.18, 0.29; P=NS).
CONCLUSIONS: Remodeling of atrial size and emptying function is much greater in HF than in ATR. Whereas in ATR, electrophysiological remodeling is of prime importance in AF promotion, structural remodeling (as reflected in changes in atrial size and contraction) appears much more important in HF-induced AF.

Entities:  

Mesh:

Year:  2001        PMID: 11684069     DOI: 10.1016/s0008-6363(01)00377-7

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  19 in total

1.  Looking into the left atrial crystal ball: a ray of hope for patients with organic mitral regurgitation.

Authors:  Robert A Levine; Stanley Nattel
Journal:  J Am Coll Cardiol       Date:  2010-08-10       Impact factor: 24.094

2.  Hypertension associated with atrial fibrillation.

Authors:  Wilbert S Aronow
Journal:  Ann Transl Med       Date:  2017-12

Review 3.  Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications.

Authors:  Bandar Al Ghamdi; Walid Hassan
Journal:  J Atr Fibrillation       Date:  2009-06-01

Review 4.  Is extensive atrial fibrosis in the setting of heart failure associated with a reduced atrial fibrillation burden?

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2018-09-09       Impact factor: 1.976

5.  Increased left atrial size is associated with higher atrial fibrillation recurrence in patients treated with antiarrhythmic medications.

Authors:  Saarang Mulukutla; Andrew D Althouse; Sandeep K Jain; Samir Saba
Journal:  Clin Cardiol       Date:  2018-06-07       Impact factor: 2.882

6.  Alterations in atrial electrophysiology and tissue structure in a canine model of chronic atrial dilatation due to mitral regurgitation.

Authors:  Sander Verheule; Emily Wilson; Thomas Everett; Sujata Shanbhag; Catherine Golden; Jeffrey Olgin
Journal:  Circulation       Date:  2003-05-05       Impact factor: 29.690

7.  Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the management of atrial fibrillation.

Authors:  Rafik R Anis
Journal:  Exp Clin Cardiol       Date:  2009

Review 8.  Information learned from animal models of atrial fibrillation.

Authors:  J Emanuel Finet; David S Rosenbaum; J Kevin Donahue
Journal:  Cardiol Clin       Date:  2009-02       Impact factor: 2.213

Review 9.  Diastolic dysfunction and atrial fibrillation.

Authors:  Rangadham Nagarakanti; Michael Ezekowitz
Journal:  J Interv Card Electrophysiol       Date:  2008-02-09       Impact factor: 1.900

Review 10.  Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation.

Authors:  Gerald V Naccarelli; Frank Peacock
Journal:  Vasc Health Risk Manag       Date:  2009-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.